Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Fungal heat-shock proteins in human disease.

Burnie JP, Carter TL, Hodgetts SJ, Matthews RC.

FEMS Microbiol Rev. 2006 Jan;30(1):53-88. Review.

2.

Human recombinant antibody to HSP90: a natural partner in combination therapy.

Matthews RC, Burnie JP.

Curr Mol Med. 2005 Jun;5(4):403-11. Review.

PMID:
15977996
3.
4.

An outbreak of imipenem-resistant Pseudomonas aeruginosa in an intensive care unit.

Majumdar S, Kirby A, Berry N, Williams C, Hassan I, Eddleston J, Burnie JP.

J Hosp Infect. 2004 Oct;58(2):160-1. No abstract available.

PMID:
15474190
5.

Recombinant antibodies: a natural partner in combinatorial antifungal therapy.

Matthews RC, Burnie JP.

Vaccine. 2004 Feb 17;22(7):865-71. Review.

PMID:
15040939
6.

Clostridium difficile, atopy and wheeze during the first year of life.

Woodcock A, Moradi M, Smillie FI, Murray CS, Burnie JP, Custovic A.

Pediatr Allergy Immunol. 2002 Oct;13(5):357-60.

PMID:
12431195
7.

Neutralising human recombinant antibodies to human cytomegalovirus glycoproteins gB and gH.

Nejatollahi F, Hodgetts SJ, Vallely PJ, Burnie JP.

FEMS Immunol Med Microbiol. 2002 Nov 15;34(3):237-44.

8.
9.

Identification of an immunodominant drug efflux pump in Burkholderia cepacia.

Wigfield SM, Rigg GP, Kavari M, Webb AK, Matthews RC, Burnie JP.

J Antimicrob Chemother. 2002 Apr;49(4):619-24.

PMID:
11909835
10.

Recurrent Escherichia coli bacteraemia in a patient with chronic renal failure.

Adedeji A, Subudhi CP, Hutchison AJ, Burnie JP, Kerr JR.

Nephrol Dial Transplant. 2001 Dec;16(12):2429-30. No abstract available.

PMID:
11733641
11.

The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections.

Polonelli L, Casadevall A, Han Y, Bernardis F, Kirkland TN, Matthews RC, Adriani D, Boccanera M, Burnie JP, Cassone A, Conti S, Cutler JE, Frazzi R, Gregory C, Hodgetts S, Illidge C, Magliani W, Rigg G, Santoni G.

Med Mycol. 2000;38 Suppl 1:281-92. Review.

PMID:
11204156
12.

An association between sudden infant death syndrome (SIDS) and Helicobacter pylori infection.

Kerr JR, Al-Khattaf A, Barson AJ, Burnie JP.

Arch Dis Child. 2000 Nov;83(5):429-34.

13.

A PCR-based approach to sequence the Candida tropicalis HSP90 gene.

Santhanam J, Burnie JP.

FEMS Immunol Med Microbiol. 2000 Sep;29(1):35-8.

14.

Identification of an immunodominant ABC transporter in methicillin-resistant Staphylococcus aureus infections.

Burnie JP, Matthews RC, Carter T, Beaulieu E, Donohoe M, Chapman C, Williamson P, Hodgetts SJ.

Infect Immun. 2000 Jun;68(6):3200-9.

15.

Analysis of antibody response to Cryptococcus neoformans in five patients with AIDS and cryptococcosis by immunoblotting.

Lamura L, Matthews RC, Barchiesi F, Donahoe M, Burnie JP, Scalise G.

J Infect. 2000 Jan;40(1):64-8.

PMID:
10762114
16.

The Bpel locus encodes type III secretion machinery in Bordetella pertussis.

Kerr JR, Rigg GP, Matthews RC, Burnie JP.

Microb Pathog. 1999 Dec;27(6):349-67.

PMID:
10588908
17.
18.

Stress proteins in fungal diseases.

Matthews RC, Maresca B, Burnie JP, Cardona A, Carratu L, Conti S, Deepe GS, Florez AM, Franceschelli S, Garcia E, Gargano LS, Kobayashi GS, McEwen JG, Ortiz BL, Oviedo AM, Polonelli L, Ponton J, Restrepos A, Storlazzi A.

Med Mycol. 1998;36 Suppl 1:45-51. Review.

PMID:
9988491
19.

Is infection control an academic study?

Burnie JP.

J Hosp Infect. 1999 Jan;41(1):7-10. Review.

PMID:
9949958
20.

The renaissance of antibody therapy.

Burnie JP, Matthews RC.

J Antimicrob Chemother. 1998 Mar;41(3):319-22. Review. No abstract available.

PMID:
9578156
21.

Epitope mapping Candida albicans proteinase (SAP 2).

Ghadjari A, Matthews RC, Burnie JP.

FEMS Immunol Med Microbiol. 1997 Oct;19(2):115-23.

23.
24.

Candida inconspicua, a fluconazole-resistant pathogen in patients infected with human immunodeficiency virus.

Baily GG, Moore CB, Essayag SM, de Wit S, Burnie JP, Denning DW.

Clin Infect Dis. 1997 Jul;25(1):161-3. No abstract available.

PMID:
9243058
25.
26.

Semiquantitative polymerase chain reaction enzyme immunoassay for diagnosis of disseminated candidiasis.

Burnie JP, Golbang N, Matthews RC.

Eur J Clin Microbiol Infect Dis. 1997 May;16(5):346-50.

PMID:
9228473
27.

Ciprofloxacin-resistant Staphylococcus epidermidis and hands.

Burnie JP, Loudon KW.

Lancet. 1997 Mar 1;349(9052):649. No abstract available.

PMID:
9057750
28.

Sensitive and universal method for microbial DNA extraction from blood products.

Golbang N, Burnie JP, Klapper PE, Bostock A, Williamson P.

J Clin Pathol. 1996 Oct;49(10):861-3.

29.
30.

Defining antibody targets in Streptococcus oralis infection.

Burnie JP, Brooks W, Donohoe M, Hodgetts S, al-Ghamdi A, Matthews RC.

Infect Immun. 1996 May;64(5):1600-8.

31.

Kitchens as a source of Aspergillus niger infection.

Loudon KW, Coke AP, Burnie JP, Shaw AJ, Oppenheim BA, Morris CQ.

J Hosp Infect. 1996 Mar;32(3):191-8.

PMID:
8690882
32.

Karyotyping of fluconazole-resistant yeasts with phenotype reported as Candida krusei or Candida inconspicua.

Essayag SM, Baily GG, Denning DW, Burnie JP.

Int J Syst Bacteriol. 1996 Jan;46(1):35-40.

PMID:
8573520
33.

Comparison of three typing methods for clinical and environmental isolates of Aspergillus fumigatus.

Loudon KW, Burnie JP.

J Clin Microbiol. 1995 Dec;33(12):3362-3. No abstract available.

34.
35.
36.

Allergic and invasive aspergillosis.

Burnie JP.

J R Soc Med. 1995;88 Suppl 25:41-5. Review. No abstract available.

37.

Defining potential targets for immunotherapy in Burkholderia cepacia infection.

Burnie JP, al-Wardi EJ, Williamson P, Matthews RC, Webb K, David T.

FEMS Immunol Med Microbiol. 1995 Jan;10(2):157-64.

PMID:
7536517
38.

Human recombinant antibodies and immunotherapy.

Matthews RC, Burnie JP.

FEMS Immunol Med Microbiol. 1994 Jun;9(1):1-6. Review. No abstract available.

PMID:
7920459
39.
40.

Invasive aspergillosis: clusters and sources?

Loudon KW, Coke AP, Burnie JP, Lucas GS, Liu Yin JA.

J Med Vet Mycol. 1994;32(3):217-24.

PMID:
7965492
41.

Epitope mapping human heat shock protein 90 with sera from infected patients.

al-Dughaym AM, Matthews RC, Burnie JP.

FEMS Immunol Med Microbiol. 1994 Jan;8(1):43-8.

PMID:
7512400
42.
43.

Clamped homogeneous electric field gel electrophoresis typing of Torulopsis glabrata isolates causing nosocomial infections.

Khattak MN, Burnie JP, Matthews RC, Oppenheim BA.

J Clin Microbiol. 1992 Aug;30(8):2211-5.

44.

Clinical applications of molecular biology to diagnostic microbiology.

Matthews RC, Burnie JP.

J Clin Pathol. 1992 Jun;45(6):465-7. Review. No abstract available.

45.

Restriction endonuclease analysis of Aspergillus fumigatus DNA.

Burnie JP, Coke A, Matthews RC.

J Clin Pathol. 1992 Apr;45(4):324-7.

46.

Is Bordetella pertussis clonal?

Khattak MN, Matthews RC, Burnie JP.

BMJ. 1992 Mar 28;304(6830):813-5.

47.

Antigen detection in invasive aspergillosis.

Burnie JP.

J Immunol Methods. 1991 Oct 25;143(2):187-95.

PMID:
1940388
48.

Heat shock protein 88 and Aspergillus infection.

Burnie JP, Matthews RC.

J Clin Microbiol. 1991 Oct;29(10):2099-106.

49.

The application of epitope mapping in the development of a new serological test for systemic candidosis.

Matthews R, Burnie JP, Lee W.

J Immunol Methods. 1991 Sep 20;143(1):73-9.

PMID:
1717606
50.

Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis.

Matthews RC, Burnie JP, Howat D, Rowland T, Walton F.

Immunology. 1991 Sep;74(1):20-4.

Supplemental Content

Loading ...
Support Center